CMF6 Acromegaly: Navigating the Difficult Cases

Program: Case Management Forums
Clinical Session
Sunday, April 3, 2016: 10:00 AM-10:45 AM
BR East (BCEC)
Sunday, April 3, 2016: 2:15 PM-3:00 PM
BR East (BCEC)
Speakers:
Peter J. Trainer, MD, FRCP, The Christie NHS Foundation Trust, Manchester, United Kingdom and Katja Kiseljak-Vassiliades, DO, University of Colorado School of Medicine and Research Service VAMC, Aurora, CO

Disclosures:
PJT: Principal Investigator, Ipsen, Principal Investigator, also unpaid advisory board member, Principal Investigator, Antisense Therapeutics, Principal Investigator, Chiasma, also unpaid advisory board member. KK: Coinvestigator, Novo Nordisk, Coinvestigator, Novartis Pharmaceuticals, Principal Investigator, Pfizer, Inc..
See more of: Case Management Forums

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire